
About Olive Lifesciences Private Limited
Data last updated:
Olive Lifesciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 18 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2007PTC043892. Its GSTIN is 29AABCO1065F1ZM (Karnataka). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹58.95 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Juie Hilal and Ramesh Krishnan (Person Incharge).
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 5805/05 NH – 4 Near Navayuga Toll Gate Nelamangala, Bangalore, Karnataka, India – 562123.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.35 Cr, a decline of 49% compared to the previous year. For the same year it recorded a net loss of ₹6.79 Cr (net margin -41.5%) and EBITDA of -₹5.95 Cr (EBITDA margin -36.4%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 19% over five years.
The company has about 32 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Olive life sclence. As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹111.01 Cr on record. Court records list 22 cases involving the company, including 10 filed by the company and 12 filed against it; 7 cases are pending. The company has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹44.7 Cr; the latest was in September 2020. The company has 5 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 9 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website olivelifesciences.com.
Company details
Contact details
Olive Lifesciences Private Limited's registered office is in Bangalore, Karnataka. Its website is olivelifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo. 5805/05 NH – 4 Near Navayuga Toll Gate Nelamangala, Bangalore, Karnataka, India – 562123
- IndustryHealthcare, Preventive Health Supplements
To see the full contact details of Olive Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Olive Lifesciences operates one associated brand: Olive life sclence. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer and supplier of nutraceuticals, cosmeceuticals and pharmaceuticals | olivelifesciences.com |
Business activity
The main business activity of Olive Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Olive Lifesciences Private Limited, buy the company report.
Financials of Olive Lifesciences Private Limited
FY 2025 filings availableOlive Lifesciences Private Limited reported revenue of ₹16.35 Cr (down 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 49% fall in the latest year. EBITDA fell 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -36.4% | ||||
| Net Profit Margin | -41.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Olive Lifesciences Private Limited, buy the company report.
Board of directors of Olive Lifesciences Private Limited
Olive Lifesciences has 5 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Juie Hilal | Director | 18 Sep 2007 | 19 Years 1 Months | Current |
| Ramesh Krishnan Also directs: Fynergy Corporate Advisors LLP | Person Incharge | 03 Feb 2014 | 12 Years 9 Months | Current |
| Parandaman Srinivasan | Person Incharge | 03 Feb 2014 | 12 Years 9 Months | Current |
| Anver | Director | 01 Jul 2025 | 1 Years 4 Months | Current |
| Shainy Anver | Director | 01 Jul 2025 | 1 Years 4 Months | Current |
Auditor
Olive Lifesciences Private Limited is audited by Lingaraj Pujari & Co., for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Lingaraj Pujari & Co., | FY 2024 | 014503S |
Shareholding
The shareholding of Olive Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Olive Lifesciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Mar 2015 | 10558791 | Hdfc Bank Limited | ₹10 Cr | Satisfied | |
| 19 Mar 2014 | 10501373 | Hdfc Bank Limited | ₹5 Cr | Satisfied | |
| 02 Jan 2014 | 10474671 | Hdfc Bank Limited | ₹15 Cr | Satisfied | |
| 02 Jan 2014 | 10473950 | Hdfc Bank Limited | ₹15 Cr | Satisfied | |
| 26 Dec 2013 | 10470202 | Axis Bank Limited | ₹17.5 Cr | Satisfied |
To see the full charge records of Olive Lifesciences Private Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Olive Lifesciences Private Limited has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹44.7 Cr; the latest was in September 2020.
Deals on record (4 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2010 | Funding round | ₹2.95 Cr | Investors: 4 individuals |
| Aug 2009 | Funding round | ₹49 Lakh | Investors: 3 individuals |
| Dec 2008 | Funding round | ₹1.26 Cr | Investors: 4 individuals |
To see the full deal history of Olive Lifesciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Olive Lifesciences Private Limited has 22 court cases on record: 10 filed by Olive Lifesciences, 12 filed against it. 7 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 6 | 5 |
| District courts | 6 | 5 | 2 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Arbitration matter | Filed against the company by M/S Biomed Ingredients Pvt Ltd | Pending |
| High Court, KARNATAKA | Writ petition | Filed by the company against Garuda Developers Private Limited | Pending |
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed against the company by M/S Garuda Developers Private Limited | Pending |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by M/S Biomed Ingredients Pvt. Ltd | Disposed |
| District court, BENGALURU RURAL, Karnataka | Court case (Com.O.S.) | Filed by the company against Biomed Ingredients Private Limited | Disposed |
To see the full case history of Olive Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Olive Lifesciences Private Limited was last rated by Brickwork on 28 Jun 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 28 Jun 2021 |
To see the full credit ratings and regulatory alerts of Olive Lifesciences Private Limited, buy the company report.
MSME payment delays
Olive Lifesciences Private Limited has 5 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ingex Botanicals Limited | |||
| Eurofins Analytical Services India Private Limited | |||
| an individual supplier | |||
| Ambe Phytoextracts Private Limited | |||
| The Bangalore Sales Corporation |
To see the full MSME payment records of Olive Lifesciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Olive Lifesciences Private Limited has a workforce of 32 employees on its EPFO records as of Mar 25, 2025, across 1 active EPFO establishment.
GST
Olive Lifesciences has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCO1065F1ZM | Karnataka | Active | 01 Jul 2017 |
| 33AABCO1065F2ZW | Tamil Nadu | Active | 25 Mar 2023 |
To see the full GST registrations and return filing status of Olive Lifesciences Private Limited, buy the company report.
Recent activity
Olive Lifesciences Private Limited has 15 board changes on record since 2007: 5 appointments and 10 cessations. The latest: Anver ceased to be Additional Director on 21 Sep 2025.
43 earlier events are in the company report.
Frequently asked questions
Olive Lifesciences is an active private limited company based in Bangalore, Karnataka, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 18 September 2007 (19+ years old) and is registered under CIN U24230KA2007PTC043892.
Olive Lifesciences has 5 current directors:
- Juie Hilal - Director
- Anver - Director
- Shainy Anver - Director
- Ramesh Krishnan - Person Incharge
- Parandaman Srinivasan - Person Incharge
The latest financial statements of Olive Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Olive Lifesciences is 29AABCO1065F1ZM, registered in Karnataka. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 33AABCO1065F2ZW (Tamil Nadu).
The CIN (Corporate Identification Number) of Olive Lifesciences is U24230KA2007PTC043892. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Olive Lifesciences has 22 court cases on record: 10 filed by the company and 12 filed against it. 7 are pending. Most are in the high courts.
Olive Lifesciences was incorporated on 18 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
Olive Lifesciences has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹44.7 Cr; the latest was in September 2020.
Anver ceased to be Additional Director on 21 Sep 2025. Shainy Anver ceased to be Additional Director on 21 Sep 2025. Anver was appointed as Director on 01 Jul 2025. Olive Lifesciences has 15 board changes on record in total.
Olive Lifesciences has 5 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 9 micro and small suppliers. The latest return was filed on 02 May 2024.
Olive Lifesciences can be reached through the website olivelifesciences.com. Its registered office is in Bangalore, Karnataka, India.

